Durgical
EN
Open the app

Laboratory diagnosis of fungal infections

  • Laboratory diagnosis

Fungi are found by looking (KOH, stains, tissue), growing them, and detecting their wall or capsule antigens in blood.

Updated

What it is

Fungal diagnosis combines direct microscopy, histopathology, culture and non-culture tests. Seeing fungi invading tissue proves infection, while culture names the species and allows susceptibility testing. Antigen and cell-wall markers in blood or fluids, such as galactomannan, beta-D-glucan and cryptococcal antigen, give earlier answers in immunocompromised patients.

Key facts

  • Dimorphic fungi are molds in the environment and in culture at room temperature, and yeasts or spherules in tissue at body temperature.
  • Tissue clues: Histoplasma as tiny yeasts inside macrophages; Paracoccidioides as a large yeast with many buds ('pilot's wheel'); Coccidioides as spherules full of endospores; Sporothrix as cigar-shaped yeasts.
  • Pneumocystis cannot be cultured: it is shown by fluorescent antibody or silver stains, or PCR, on induced sputum or bronchoalveolar lavage.
  • Candida in sputum is usually colonization; in blood it is always significant.
  • Fungal cultures of CSF are often negative and may take up to two weeks, so negative results do not exclude fungal meningitis.

Step by step

  1. The host and syndrome name the suspects: neutropenia points to Aspergillus or Mucorales, advanced HIV to Cryptococcus, Histoplasma or Pneumocystis.
  2. Send tissue or fluid from the affected site, plus the blood or fluid marker that matches the suspect.
  3. Direct microscopy (KOH, calcofluor, stains) gives a same-day clue but does not name the species.
  4. Galactomannan, beta-D-glucan, cryptococcal or Histoplasma antigen give early answers when tissue is hard to obtain.
  5. Histopathology showing fungi inside tissue separates true infection from colonisation.
  6. Culture or molecular identification names the species and allows susceptibility testing; dimorphic mold plates are opened only in a safety cabinet.

Tests for fungal infection

TestWhat it showsTypical usePitfall
KOH or calcofluor mountHyphae, yeasts and pseudohyphaeSkin, nail and hair scrapings; vaginal fluid; Malassezia 'spaghetti and meatballs'Needs a good scraping; does not name the species
Histopathology (silver and PAS stains)Fungi invading tissueNarrow septate hyphae with acute-angle branching (Aspergillus) vs broad ribbon-like hyphae with few septa (Mucorales)Shape suggests but does not confirm the genus
Culture (Sabouraud and other fungal media)Growth for identification and susceptibilityYeasts in days; molds and dimorphic fungi over days to weeksSlow; dimorphic mold cultures are a lab biosafety hazard
GalactomannanAspergillus cell-wall polysaccharide in serum or bronchoalveolar lavageInvasive aspergillosis in neutropenia and transplantFalse positives occur; negative in mucormycosis
Beta-D-glucanCell-wall component shared by many fungiCandida, Aspergillus, PneumocystisNot specific; usually negative for Cryptococcus and Mucorales
Cryptococcal antigenCapsular polysaccharide in serum or CSFCryptococcal meningitis; screening in advanced HIVVery sensitive and specific; India ink is less sensitive
Histoplasma antigenAntigen in urine or serumDisseminated histoplasmosis in advanced HIVCross-reacts with other dimorphic fungi
Mass spectrometry, PCR and sequencingSpecies identificationCandida auris and rare moldsNeeds updated libraries; older biochemical systems misidentify C. auris

In the lab

  • Plates suspected of growing Histoplasma, Coccidioides or Blastomyces are opened only inside a biological safety cabinet, because their spores infect by inhalation.
  • In Colombia, histoplasmosis and paracoccidioidomycosis are the main endemic mycoses, and cryptococcosis is under laboratory surveillance by the national reference laboratory.

Common traps

  • Candida grown from sputum means Candida pneumonia: it usually reflects colonisation of the mouth and airway, whereas Candida in blood always counts.
  • A negative beta-D-glucan rules out invasive fungal infection: it is usually negative in cryptococcosis and mucormycosis, so tissue or the specific antigen is still needed.
  • A negative fungal CSF culture excludes fungal meningitis: CSF cultures are often negative and slow, so cryptococcal antigen in serum and CSF is the key test.
  • Hyphae in tissue identify the exact genus: acute-angle septate versus broad ribbon-like hyphae only suggest Aspergillus or Mucorales, and culture or molecular tests confirm, which matters because they are treated differently.
  • Any yeast identified by a routine biochemical system is reliable: Candida auris is often misidentified that way and needs mass spectrometry with updated libraries or sequencing.

Test yourself

Think of the answer, then tap the question to see it.

A patient with leukaemia and neutropenia has fever and new lung nodules; serum galactomannan is positive. What does this suggest, and what are its limits?

Invasive aspergillosis is likely; false positives occur and the test is negative in mucormycosis, so imaging, lavage and tissue or culture complete the picture.

A patient with diabetic ketoacidosis has a black necrotic nasal lesion; galactomannan and beta-D-glucan are negative. Is fungal infection excluded?

No. Mucormycosis is typically negative for both markers; diagnosis relies on tissue showing broad ribbon-like hyphae with few septa, and on culture.

A patient with advanced HIV has headache and fever; India ink on CSF is negative. What test should follow?

Cryptococcal antigen in CSF and serum, which is far more sensitive than India ink; opening pressure is also measured at the lumbar puncture.

A patient with advanced HIV in Colombia has fever, weight loss and enlarged liver and spleen. Which non-invasive test helps, and what is its catch?

Histoplasma antigen in urine or serum supports disseminated histoplasmosis; it cross-reacts with other dimorphic fungi such as Paracoccidioides.

An ICU yeast from blood is reported as an unusual Candida species by an older biochemical system. Why should the lab confirm it, and how?

Candida auris is often misidentified by such systems; mass spectrometry with an updated library or sequencing confirms it, which matters for treatment and infection control.

Add to my cards (5)

Connections

← General microbiology

Educational content on microorganisms; not a treatment guide and no substitute for a health professional's advice. No doses are given.

Sources: Clinical Overview of Aspergillosis (CDC, 2024); Clinical Overview of Cryptococcosis (CDC, 2024); Identification of C. auris (CDC, 2024); Clinical Overview of Fungal Meningitis (CDC, 2024).

Spotted a mistake?We are always improving for the community. Tell us what is wrong and our team will review it.Report a mistake

Representative model, for educational purposes only.